G6PD and cervical carcinoma: These findings, together with our results, indicate that miR-1 inhibits proliferation and promotes apoptosis in cervical cancer both in vitro and in vivo by targeting G6PD, suggesting that G6PD-targeting treatments may provide a new strategy for cervical cancer therapy.